Post-Dental and Alveolar Nerve-Related Trigeminal Pain in Patients Referred with Trigeminal Neuralgia Terminology: A Retrospective Tertiary-Center Diagnostic Pathway Study. [PDF]
Shemesh SZ +5 more
europepmc +1 more source
Aims Ocrelizumab is a humanized anti‐CD20 monoclonal antibody used in multiple sclerosis. Since its commercialization, several cases of ocrelizumab‐induced colitis have been reported in the scientific literature. Methods To explore the potential association of ocrelizumab with colitis as an adverse drug reaction (ADR), we conducted a descriptive and ...
Audrey Fresse +3 more
wiley +1 more source
Tree-ring width and δ<sup>18</sup>O-derived hydroclimatic reconstructions allow a distinction between soil and atmospheric drought in the Mountain Forests of Northeastern Iran. [PDF]
Foroozan ZP +5 more
europepmc +1 more source
Precision medicine in paediatrics: Progress and priorities
Precision medicine is revolutionizing personalized healthcare, advancing both diagnostics and therapeutics at an unprecedented pace. Reviewing the paediatric applications of pharmacometrics, pharmacogenomics and advanced therapy medicinal products highlights not only the relevance of these exciting innovations to frontline care but also the significant
Nicola Husain +3 more
wiley +1 more source
Dynamic stability of climate-growth relationships in <i>Picea crassifolia</i> in the Qilian Mountains: the modulating role of elevation gradient and time-varying characteristics. [PDF]
Zhao J +11 more
europepmc +1 more source
Abstract Aim Sirolimus is currently used off‐label for paediatric patients with vascular anomalies. However, the optimal dosage regimen for paediatric patients remains controversial. This study aimed to determine the optimal dosing regimen of sirolimus in these patients using a population pharmacokinetic (PK) model.
Seongmee Jeong +13 more
wiley +1 more source
Chronologically distributed transfection improves AAV2 and AAV2/8 capsid filling and reveals assembly schedule divergence. [PDF]
Chen Q, Lee CH, Whitfield R, Nesbeth DN.
europepmc +1 more source
Abstract Aims Enzyme replacement therapy (ERT) for mucopolysaccharidosis II (MPS II) requires long‐term, weekly intravenous infusions often lasting over 3 h each time, which can burden paediatric patients and caregivers and negatively affect their quality of life and treatment compliance.
Kimitoshi Nakamura +6 more
wiley +1 more source
Response by Chirumbolo to "Rare Localized Adverse Reaction to Botulinum Toxin Type A in a Patient Without Allergic History: A Case Report" by Muner et al. [PDF]
Chirumbolo S.
europepmc +1 more source

